When crossed onto a mouse Fxn-null genotype, these transgenic mice act as suitable models to study the molecular mechanisms of FXN dysfunction and to investigate FRDA therapeutic strategies [19]–[24]. The gene discussed is FXN; the disease is Friedreich ataxia.